Plandaí Biotechnology, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLPL research report →
About the company
Plandaí Biotechnology, Inc. specializes in developing distinctive botanical extracts intended for the nutriceutical and pharmaceutical industries. A primary focus is the development of its Phytofare Catechin Complex, an extract originating from green tea cultivated at the Senteeko Tea Estate in Mpumalanga, South Africa.
- CEO
- Roger Baylis-Duffield
- IPO
- 1995
- Employees
- 180
- HQ
- London, GB
Price Chart
- Market Cap
- $448.89K
- P/E
- -5.91
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -5.91
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
- Revenue
- $0 · 0.00%
- Net Income
- $-2,446 · -100.02%
- EPS
- $0.00 · -100.00%
- Op Income
- $-57,446
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 9.73
- Avg Volume
- 16
Get TickerSpark's AI analysis on PLPL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PLPL coverage
Recent articles, reports, and earnings notes.
No research on PLPL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PLPL report →Similar companies
Peers in the same neighborhood.